Biomerica (BMRA) said Wednesday that it will implement a 1-for-8 reverse stock split of its issued and outstanding common shares on April 21.
The medical products company said the reverse stock split will help increase the bid price of the common shares, enabling it to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.
The shares are expected to begin trading on a split-adjusted basis when the market opens on April 21. The company's ticker will remain unchanged on the bourse.
Price: 0.40, Change: -0.17, Percent Change: -29.04
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.